Target-Based Biofilm Inhibition and Antibiotic Enhancement Strategy by MiR.101.3p Using DNA Tetrahedrons
Journal of Innate Immunity · 2025
DOI: 10.1159/000549134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Innate Immunity, 2025. Verfasst von Yin He Richard Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, RSCI University of Medicine and Health Sciences, Dublin, Ireland. Hauptthemen laut MEDLINE: MicroRNAs, Oligonucleotides, Nanoparticle Drug Delivery System, Pseudomonas aeruginosa. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Cystic fibrosis (CF) is an inherited disease caused by mutations in the CF transmembrane conductance regulator gene (CFTR). It is characterized by progressive decline in lung function, often driven by chronic respiratory infections, particularly with Staphylococcus aureus and Pseudomonas aeruginosa. MicroRNAs (miRNAs), small noncoding regulatory RNAs that negatively regulate protein expression by binding to mRNA, are altered in people with CF and potentially contribute to the pulmonary manifestations of CF. The management of CF lung infections is further complicated by the formation of bacterial biofilms and the emergence of antimicrobial resistance which renders conventional treatments ineffective.
Methods
In silico analysis identified hsa-miR.101.3p as a promising miRNA with potential targets including genes associated with beta-lactam resistance and biofilm formation in P. aeruginosa, as well as genes involved in the overall growth of S. aureus. To facilitate delivery, miRNA mimic DNA oligonucleotides were conjugated to DNA tetrahedrons (DNAtds). The structural integrity of the DNAtd-miRNA complexes was confirmed via transmission electron microscopy, characterized by nanoparticle tracking analysis, and successful bacterial uptake was verified using fluorescence microscopy.
Results
DNAtd-miR.101.3p significantly reduced the viability of both S. aureus and P. aeruginosa. Furthermore, DNAtd-miR.101-3p enhanced the activity of the beta-lactam antibiotic cefotaxime against both non-mucoid and mucoid planktonic and biofilm-forming P. aeruginosa. The mechanisms involve DNAtd-miR.101.3p targeting of ampC, fleN, and pslK.
Conclusion
DNAtd-miR.101.3p displays unique inhibition properties against P. aeruginosa and S. aureus in the exponential phase of bacterial growth in vitro and increases the rate of the bactericidal activity of cefotaxime against P. aeruginosa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Microbiology, RSCI University of Medicine and Health Sciences, Dublin, Ireland.
- Department of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
- Department of Microbiology, Connolly Hospital, Dublin, Ireland.
- Department of Clinical Microbiology, RSCI University of Medicine and Health Sciences, Dublin, Ireland, cmgreene@rcsi.ie.
Zitieren
APA
Sun, Y. H. R., Ye, Y., Shahrour, H., Oglesby, I. K., O Apos Neill, E., & Greene, C. M. (2025). Target-Based Biofilm Inhibition and Antibiotic Enhancement Strategy by MiR.101.3p Using DNA Tetrahedrons. Journal of Innate Immunity. https://doi.org/10.1159/000549134
Vancouver
Sun YHR, Ye Y, Shahrour H, Oglesby IK, O Apos Neill E, Greene CM. Target-Based Biofilm Inhibition and Antibiotic Enhancement Strategy by MiR.101.3p Using DNA Tetrahedrons. Journal of Innate Immunity. 2025. doi:10.1159/000549134
BibTeX
@article{Sun2025,
author = {Sun, Yin He Richard and Ye, Yunfei and Shahrour, Hawraa and Oglesby, Irene K and O Apos Neill, Eoghan and Greene, Catherine M},
title = {Target-Based Biofilm Inhibition and Antibiotic Enhancement Strategy by MiR.101.3p Using DNA Tetrahedrons},
journal = {Journal of Innate Immunity},
year = {2025},
doi = {10.1159/000549134}
}
EUVIMED